Dana-Farber celebrates cancer survivorship in June with Living Proof, an annual series of events that includes workshops and programs as well as a keynote reception on June 20. The end of treatment is an important milestone for any cancer patient, but it can also be a time of anxiety. In fact, some new cancer survivors say leaving the routine of regular visits with their health care team can be downright scary. That’s why Dana-Farber and other leading cancer centers offer programs to help survivors transition from active treatment to living well beyond cancer.
By Patrick Y. Wen, MD and David Reardon, MD Highly malignant brain tumors called glioblastomas are the most common primary cancer of the brain; about 11,000 cases are diagnosed every year in the United States. Patrick Y. Wen, MD (Director) and David Reardon, MD, (Medical Director) of the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center describe the efforts to improve care for these patients.
When solid tumors are diagnosed, they are often assigned a grade and a stage. The grade of a tumor is an indication of how quickly it is likely to grow and spread. In general, low-grade tumors grow slowly and higher-grade tumors grow more rapidly. Tumors are assigned a grade based on the appearance of their cells under a microscope: Low-grade tumor cells resemble normal cells more closely than high-grade tumor cells do.
By Robert Haddad, MD Human papillomavirus, or HPV, vaccinations were originally advised only for girls. The Centers for Disease Control and Prevention (CDC) and the American College of Pediatrics now recommend that both girls and boys be vaccinated. The recommendations are well founded: HPV infection is the number one cause of oropharyngeal cancer, which occurs in the middle part of the throat and is diagnosed in about 14,000 Americans each year. Men are three times more likely than women to develop oropharyngeal cancers linked to HPV.
By Wendy Chen, MD Dana-Farber Breast Oncology Center Susan F. Smith Center for Women’s Cancers Millions of women in the United States have sought treatment for fertility-related problems over the past 35 years. Because many of these treatments –including fertility drugs and in vitro fertilization (IVF) – use hormones to stimulate ovulation, researchers have explored whether such therapies might increase the risk of breast or ovarian cancer.
By Vish Viswanath, PhD News about advances in cancer research and treatment appears almost daily. The pace at which new findings are reported, coupled with the complexity of the underlying science, can make it difficult to know which studies are truly significant and which are less so. It’s easy to become confused when reports seem to have varying conclusions. Here are some tips for becoming a savvy consumer of cancer news.
By Lyndsay McCaffery The first year of your baby’s life is special. They come home to you this eating, pooping, screaming machine and twelve months later they are their own walking and babbling little person. It is a year to truly cherish because you realize what parents mean when they say, “they grow up so fast.” Well, my baby’s year is going by incredibly fast. He is a crawling, smiling, happy boy. Meanwhile, I feel I have hardly moved at all. A shocking diagnosis interfered with what was supposed to be the happiest time in my life. What do you …
By Kelley Tuthill Hair loss can be a jarring side effect of chemotherapy. When I was treated for breast cancer, I was nervous about my appearance and decided to wear a wig. At first it was a strange experience, but wearing a wig helped me face the day — and a TV audience. Here are five tips I learned for selecting a wig and wearing it with confidence.